Wylie Kevan R, Ralph David
Porterbrook Clinic, Sheffield Institute of Urology and Nephrology, University College of London, UK.
Curr Opin Urol. 2005 Nov;15(6):393-8. doi: 10.1097/01.mou.0000186844.40506.98.
The recent increase in research with regard to premature ejaculation has led to a significant number of new papers looking at the diagnosis, definition, aetiology and management of this condition.
The intravaginal ejaculatory latency time remains the primary measure of ejaculatory time although increasing bother and distress require assessment and establishment of quantifiable measures. Biological and psychogenic causes contribute to a multifactorial model of premature ejaculation with some neurobiological vulnerability. The principal treatments are selective serotonin reuptake inhibitors and behavioural cognitive interventions. New treatment interventions are under investigation.
A number of guideline papers confirm that a primary sexual history and a multimodel treatment approach provide the best approach to patients with this common condition.